Literature DB >> 23862773

Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia.

Shokichi Tsukamoto1, Chiaki Nakaseko, Masahiro Takeuchi, Kyoya Kumagai, Tsunehiko Komatsu, Hiroaki Tanaka, Satoru Hara, Masayuki Koizumi, Hidenori Imai, Akira Yokota, Masami Takeuchi, Koiti Inokuchi, Yasuhiro Matsuura, Nobuyuki Aotsuka, Hisashi Wakita.   

Abstract

Entities:  

Keywords:  eltrombopag; immune thrombocytopenia; romiplostim

Mesh：

Substances：

Year:  2013        PMID： 23862773     DOI： 10.1111/bjh.12483

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Bidirectional inefficacy or intolerability of thrombopoietin receptor agonists: new data and a concise review.

Authors:  Fabian Depré; Nasra Aboud; Beate Mayer; Abdulgabar Salama
Journal:  Blood Transfus       Date:  2017-01-25       Impact factor: 3.443

2.  Reciprocal absence of cross-resistance between eltrombopag and romiplostim in two patients with refractory immune thrombocytopenic purpura.

Authors:  Laura Scaramucci; Marco Giovannini; Pasquale Niscola; Andrea Tendas; Alessio Perrotti; Paolo De Fabritiis
Journal:  Blood Transfus       Date:  2014-10       Impact factor: 3.443

3.  Thrombopoietin Receptor Agonists Are Often Ineffective in Immune Thrombocytopenia and/or Cause Adverse Reactions: Results from One Hand.

Authors:  Fabian Depré; Nasra Aboud; Frauke Ringel; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2016-07-18       Impact factor: 3.747

4.  Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia.

Authors:  Yeo-Kyeoung Kim; Seung-Sin Lee; Sung-Hoon Jeong; Jae-Sook Ahn; Deok-Hwan Yang; Je-Jung Lee; Hyeoung-Joon Kim
Journal:  Blood Res       Date:  2015-03-24

Review 5.  Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives.

Authors:  Nicola Vianelli; Giuseppe Auteri; Francesco Buccisano; Valentina Carrai; Erminia Baldacci; Cristina Clissa; Daniela Bartoletti; Gaetano Giuffrida; Domenico Magro; Elena Rivolti; Daniela Esposito; Gian Marco Podda; Francesca Palandri
Journal:  Ann Hematol       Date:  2022-02-24       Impact factor: 4.030
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.